Literature DB >> 7848879

Where do we stand with respect to the use of peripheral blood progenitor cells?

A M Gianni.   

Abstract

Mesh：

Year:  1994        PMID： 7848879     DOI： 10.1093/oxfordjournals.annonc.a059003

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent.

Authors:  Liuyan Jiang; Sunny Malik; Mark Litzow; Dennis Gastineau; Ivana Micallef; Vivek Roy; Lawrence Solberg; Abba C Zubair
Journal:  Transfusion       Date:  2011-08-09       Impact factor: 3.157

Review 2.  Haemopoietic growth factors.

Authors:  N J Ketley; A C Newland
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

3.  Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.

Authors:  Abba C Zubair; Rhonda Grant; Wenting Wu; Han Tun; Candido Rivera; Alvaro Moreno-Aspitia; Michael Joyce; Vivek Roy; Gerardo Colon-Otero; Lawrence A Solberg
Journal:  Transfusion       Date:  2008-02-25       Impact factor: 3.157

4.  Multiple myeloma patients receiving large volume leukapheresis efficiently yield enough CD34+ cells to allow double transplants.

Authors:  A C Zubair; R Rymer; J Young; U Keeton; R Befort; B Nolot; C Evans; T Bleach; A Torloni
Journal:  J Clin Apher       Date:  2009       Impact factor: 2.821

5.  Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.

Authors:  P Pedrazzoli; C Perotti; G A Da Prada; F Bertolini; N Gibelli; L Torretta; M Battaglia; L Pavesi; P Preti; L Salvaneschi; G Robustelli della Cuna
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.